Zdrowie i gospodarka · 17/11/2017
FDA Corrects Notice on Draft Guidance for Generic Drug Development
The Food and Drug Administration is correcting a notice regarding the availability of a draft guidance for industry related to generic drug development, which was published with an incorrect docket number and originally appeared in the Federal Register on November 3, 2017.